Abbott Laboratories (ABT) Acquisitions (2009 - 2019)

Abbott Laboratories has disclosed Acquisitions across 11 years of filings, most recently posting $82.0 million for Q2 2019.

• Acquisitions for Q2 2019 came in at $82.0 million, up 355.56% year-over-year; the trailing twelve-month figure through Jun 2019 was $203.0 million (down 95.17% YoY), and the FY2017 annual result was $17.2 billion, up 21378.75% from the prior year.
• Acquisitions came in at $82.0 million for Q2 2019 at Abbott Laboratories, up from $78.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $13.0 billion in Q1 2017 to a low of $7.0 million in Q4 2016.
• The 5-year median for Acquisitions is $78.0 million (2019), against an average of $2.0 billion.
• Across the five-year window, Acquisitions surged 59271.43% in 2017 and slumped 99.81% in 2018, its largest moves.
• Abbott Laboratories' Acquisitions stood at $231.0 million in 2015, then sank by 96.97% to $7.0 million in 2016, then soared by 59271.43% to $4.2 billion in 2017, then sank by 99.57% to $18.0 million in 2018, then surged by 355.56% to $82.0 million in 2019.
• The last three Acquisitions figures came in at $82.0 million (Q2 2019), $78.0 million (Q1 2019), and $18.0 million (Q2 2018), per Business Quant data.